These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22986554)

  • 41. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
    Windhausen F; Hirsch A; Tijssen JG; Cornel JH; Verheugt FW; Klees MI; de Winter RJ;
    J Electrocardiol; 2007; 40(5):408-15. PubMed ID: 17604045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute coronary syndromes without ST-elevation -- diagnosis].
    Weber M; Hamm C
    Dtsch Med Wochenschr; 2003 Feb; 128(6):270-2. PubMed ID: 12571796
    [No Abstract]   [Full Text] [Related]  

  • 43. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome.
    Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL
    Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants].
    Bodí V; Facila L; Sanchis J; Llácer A; Núñez J; Mainar L; Gómez-Aldaraví R; Monmeneu JV; Blasco ML; Sanjuan R; Insa L; Chorro FJ
    Rev Esp Cardiol; 2002 Aug; 55(8):823-30. PubMed ID: 12199978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
    Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
    J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
    Pei Q; Sang WF; Zhao XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.
    Skvarilová M; Bulava A; Stejskal D; Adamovská S; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):83-7. PubMed ID: 16170393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation on Risk Stratification and the Prognostic Value of hs-TnT Combined with MMP-2 in Patients with Acute Coronary Syndrome.
    Li Y; Li L; Wang K; Wu P; Cui Y
    Biomed Res Int; 2021; 2021():1040171. PubMed ID: 34859099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of thrombolytic therapy on C-reactive protein in ST-segment elevation acute myocardial infarction.
    Tsakiris AK; Marnelos PG; Nearchou NS; Papadakis JE; Karatzis EN; Skoufas PD
    Hellenic J Cardiol; 2006; 47(4):218-22. PubMed ID: 16897925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive Value of Endocan Based on TIMI Risk Score on Major Adverse Cardiovascular Events After Acute Coronary Syndrome.
    Ziaee M; Mashayekhi S; Ghaffari S; Mahmoudi J; Sarbakhsh P; Garjani A
    Angiology; 2019 Nov; 70(10):952-959. PubMed ID: 30514091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction.
    Hashimoto T; Ishii J; Kitagawa F; Yamada S; Hattori K; Okumura M; Naruse H; Motoyama S; Matsui S; Tanaka I; Izawa H; Maruyama I; Nomura M; Ozaki Y
    Atherosclerosis; 2012 Apr; 221(2):490-5. PubMed ID: 22369934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice.
    Collinson PO; Stubbs PJ; Kessler AC;
    Heart; 2003 Mar; 89(3):280-6. PubMed ID: 12591831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Peterson ED; Pollack CV; Newby LK; Li Y; Christenson RH; Peacock WF; Fesmire FM; Diercks D; Kirk JD; Smith SC; Ohman EM; Gibler WB;
    Ann Emerg Med; 2005 Apr; 45(4):355-62. PubMed ID: 15795713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allergic Inflammation Is Associated With Coronary Instability and a Worse Clinical Outcome After Acute Myocardial Infarction.
    Niccoli G; Calvieri C; Flego D; Scalone G; Imaeva A; Sabato V; Schiavino D; Liuzzo G; Crea F
    Circ Cardiovasc Interv; 2015 Aug; 8(8):e002554. PubMed ID: 26243785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic implications of increased cardiac biomarkers and ST segment depression in non-ST elevation acute coronary syndromes: lessons from the acute coronary syndrome Israeli survey (ACSIS) 2002.
    Ben-Dor I; Hasdai D; Behar S; Zahger D; Leor J; Hammerman H; Sandach A; Hod H; Gottlieb S;
    Heart; 2006 Apr; 92(4):547-8. PubMed ID: 16537779
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein.
    Artieda M; Cenarro A; Gañán A; Lukic A; Moreno E; Puzo J; Pocoví M; Civeira F
    Cardiology; 2007; 108(4):297-306. PubMed ID: 17290100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Presentation, Management and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era - Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) - .
    Ishihara M; Fujino M; Ogawa H; Yasuda S; Noguchi T; Nakao K; Ozaki Y; Kimura K; Suwa S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Tsujita K; Nishimura K; Miyamoto Y;
    Circ J; 2015; 79(6):1255-62. PubMed ID: 25912696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study.
    Hirsch A; Windhausen F; Tijssen JG; Verheugt FW; Cornel JH; de Winter RJ;
    Lancet; 2007 Mar; 369(9564):827-835. PubMed ID: 17350451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study.
    Nevado JB; Imasa MS
    Coron Artery Dis; 2008 May; 19(3):153-61. PubMed ID: 18418231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.